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A new PLA
2
(Bp-13) was purified from Bothrops pauloensis snake venom after a single chromatographic step of RP-HPLC on 𝜇-
Bondapak C-18. Amino acid analysis showed a high content of hydrophobic and basic amino acids and 14 half-cysteine residues.
TheN-terminal sequence showed a high degree of homology with basic Asp49 PLA
2
myotoxins from other Bothrops venoms. Bp-13
showed allosteric enzymatic behavior and maximal activity at pH 8.1, 36∘–45∘C. Full Bp-13 PLA
2
activity required Ca2+; its PLA
2
activity was inhibited by Mg2+, Mn2+, Sr2+, and Cd2+ in the presence and absence of 1mM Ca2+. In the mouse phrenic nerve-
diaphragm (PND) preparation, the time for 50% paralysis was concentration-dependent (𝑃 < 0.05). Both the replacement of Ca2+
by Sr2+ and temperature lowering (24∘C) inhibited the Bp-13 PLA
2
-induced twitch-tension blockade. Bp-13 PLA
2
inhibited the
contractile response to direct electrical stimulation in curarized mouse PND preparation corroborating its contracture effect. In
biventer cervicis preparations, Bp-13 induced irreversible twitch-tension blockade and the KCl evoked contracture was partially,
but significantly, inhibited (𝑃 > 0.05). The main effect of this new Asp49 PLA
2
of Bothrops pauloensis venom is on muscle
fiber sarcolemma, with avian preparation being less responsive than rodent preparation. The study enhances biochemical and
pharmacological characterization of B. pauloensis venom.
1. Introduction
Phospholipase A
2
belongs to an expanding superfamily of
enzymes that catalyzes ester bond hydrolysis at the sn-2
position of 1,2-diacyl-sn-3-phosphoglycerides and generates
arachidonic acid. Depending on the molecular taxonomy,
intracellular and secretory PLA
2
s are currently classified in
six to twelve groups [1]. Secretory PLA
2
s are enzymes of
13–18 kDa with 5–8 disulfide bonds whose activity requires
millimolar Ca2+ concentration [2].
Despite the variety of the local and systemic pathophys-
iological effect, such as myotoxicity, neurotoxicity, anticoag-
ulation, hemolysis, hypotension, platelet aggregation inhibi-
tion, and bactericidal and proinflammatory activities, PLA
2
groups show highly conserved molecular regions and similar
three-dimensional structure [3]. The majority of such local
and systemic effects caused by Bothrops sp. envenomation is
often due to the PLA
2
activity [3–5]. Although generally the
neurotoxic effects are unnoticed clinically, they can be
observed during in vitro experiments and are frequently asso-
ciated with PLA
2
of bothropic venoms [6–14].
B. pauloensis is found in humid and cool regions in the
central and Southwest of the state of Sa˜o Paulo [15, 16] and in
seasonally dry savannas of the Brazilian Cerrado [17]. From
the 292 notified accidents caused by Bothrops snakes, 18%
(52 cases) were caused by B. pauloensis [18], thus evidencing
that the study of the venom of this snake species can be of
medical relevance. In this work, we describe the isolation and
Hindawi Publishing Corporation
Biochemistry Research International
Volume 2015, Article ID 826059, 11 pages
http://dx.doi.org/10.1155/2015/826059
2 Biochemistry Research International
enzymatic characterization of a highly basic PLA
2
from the
venom of B. pauloensis. We also investigated whether this
isolated PLA
2
possesses neurotoxic activity.
2. Material and Methods
2.1. Venom and Reagents. Venom was purchased from Sigma
Chemical Co. (St. Louis, MO, USA).
Solvents (HPLC grade), 4-nitro-3-octanoyloxy-benzoic
acid, sequencing grade bovine pancreatic trypsin and other
reagents were also obtained from Sigma Chemical Co. (St.
Louis, MO, USA).
2.2. Reverse Phase HPLC (RP-HPLC). Bp-13 PLA
2
from B.
pauloensis venom was purified by reverse phase HPLC,
according to the method described by Ponce-Soto et al. [19],
with minor changes. Briefly, 5mg of the whole venom was
dissolved in 200𝜇L of buffer A (0.1% TFA) and centrifuged
at 4500 g; the supernatant was then applied to a 𝜇-Bondapak
C18 column (0.78 × 30 cm; Waters 991-PDA system), previ-
ously equilibrated in buffer A for 15min. The protein elution
was then conducted using a linear gradient (0–100%, v/v) of
buffer B (66.5% acetonitrile in bufferA) at a constant flow rate
of 1.0mL/min. The chromatographic run was monitored at
280 nm of absorbance. The purity and PLA
2
activity were
monitored according to Sections 2.3 and 2.6. All fractions
eluted were lyophilized and then stored at −20∘C for further
biochemical and pharmacological assays.
2.3. Electrophoresis. Tricine SDS-PAGE in a discontinuous
gel and buffer systemwas used to estimate themolecularmass
of Bp-13 PLA
2
, under reducing and nonreducing conditions
[20]. The used molecular weight markers in kDa were
phosphorylase B: ∼ 94, albumin: 67, ovalbumin: 43, carbonic
anhydrase: 30, soybean trypsin inhibitor: 20, and 𝛼-lactoal-
bumin: 14 (GE Healthcare).
2.4. AminoAcidAnalysis. Amino acid analysiswas performed
on a Pico-Tag Analyzer (Waters Systems), as described by
Heinrikson and Meredith [21], with minor changes. Bp-13
PLA
2
sample (30 𝜇g) was hydrolyzed at 105∘C for 24 hours, in
6M HCl (Pierce sequencing grade) containing 1% phenol
(w/v). Hydrolyzates were reacted with 20 𝜇L of derivatized
solution (ethanol : triethylamine : water : phenylisothiocyanate,
7 : 1 : 1 : 1, v/v) for one hour at room temperature. Afterwards,
PTC-amino acids were identified and quantified by HPLC,
by comparing their retention times and peak areas with those
from a standard amino acid mixture (Sigma-Aldrich).
2.5. Mass Spectrometry. Molecular mass of intact native
and alkylated Bp-13 PLA
2
was analyzed by MALDI-TOF
mass spectrometry using a Voyager-DE PRO MALDI-TOF
apparatus (Applied Biosystems, Foster City, CA, USA)
equipped with a pulsed nitrogen laser (337 nm, pulse with
4 ns). The amount of 1 𝜇L of sample in 0.1% TFA was mixed
with 2𝜇L of sinapinic acid matrix (3, 5-dimethoxy-4-hydro-
xycinnamic acid). The matrix was prepared with 30% ace-
tonitrile and 0.1% TFA and its mass analyzed under the
following conditions: 25 kV accelerating voltage, the laser
fixed at 2890𝜇J/cm2, 300 ns delay, and linear analysis mode
[22].
For de novo sequencing of N-terminal, the first 52 amino
acids from Bp-13 PLA
2
, alkylated tryptic peptides were frac-
tionated by RP-HPLC, manually collected, lyophilized, and
resuspended in 80% H
2
O, 20% acetonitrile and 0.1% TFA.
One peptide was introduced separately into the mass spec-
trometer source using a syringe pump at a 500 nl/min flow
rate. Before performing a tandemmass spectrum, an ESI/MS
mass spectrum (TOFMSmode) was acquired for eachHPLC
fraction over the mass range of 400–2000 m/z, aiming to
select the ion of interest. Subsequently, these ions were frag-
mented in the collision cell (TOF MS/MS mode). Different
collision energies were used depending on the mass and
charge state of the ions. The resulting product-ion spectra
were acquired with the TOF analyzer and deconvoluted using
the MassLynx-MaxEnt 3 algorithm (Waters). Singly charged
spectra were manually processed using the PepSeq applica-
tion included in MassLynx.
2.6. PLA
2
Activity. PLA
2
activity was measured using the
assay described by Cho and Ke´zdy [23] and Holzer and
Mackessy [24] modified for 96-well plates. The standard
assay mixture contained 200𝜇L of buffer (10mM Tris–HCl,
10mM CaCl
2
, and 100mMNaCl, pH 8.0), 20 𝜇L of synthetic
chromogenic substrate 4-nitro-3- (octanoyloxy) benzoic acid
3mM, 20𝜇L of water, and 20 𝜇L of PLA
2
fractions (1mg/mL)
or whole venom (1mg/mL) in a final volume of 260 𝜇L. After
adding the samples, the mixture was incubated for up to
40min at 37∘C, absorbance reading at intervals of 10min.The
enzyme activity, expressed as the initial velocity of the reac-
tion (𝑉
0
), was calculated based on the increase of absorbance
after 20min.
The pH and optimal temperature of PLA
2
were deter-
mined by incubating the four reaction buffers with different
pH ranging from 4 to 10 and at different temperatures,
respectively. The effect of substrate concentration (40, 20, 10,
5, 2.5, 1.0, 0.5, 0.3, 0.2, and 0.1mM) on enzyme activity was
determined by measuring the increase of absorbance after
20min in optimum pH and temperature. The effect of differ-
ent concentration of Ca2+ on Bp-13 PLA
2
enzymatic activity
was tested by preincubating the enzyme with different ion
concentrations (0.005, 0.025, 0.05, 0.1, 0.2, 0.3, 0.4, and 0.5M)
at 37∘C for 30minutes prior to standard experiment. Also, the
effects of different divalent ions (Sr2+, Mg2+, Mn2+, and Cd2+,
5mM) were tested in presence (1mM) or absence of Ca2+.
Finally the effect of urea (4M) on the enzymatic activity was
tested by preincubating Bp-13 for 30 minutes at 37∘C.
All assays were done in triplicate and the absorbance at
425 nm was measured using a VersaMax 190 multiwell plate
reader (Molecular Devices, Sunnyvale, CA, USA).
2.7. BC, PND, and EDL Nerve-Muscle Preparations. Male
Swiss mice (Mus musculus) weighing 20–30 g and 8-day-old
young chick (Hy Line W36) were used for twitch-tension
studies in presence of Bp-13 PLA
2
. Mice and young chick
were sacrificed by halothane inhalation.The hemidiaphragm
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Figure 1: RP-HPLC chromatography of Bothrops pauloensis venom on 𝜇-Bondapak C 18 column (0.78 cm × 30 cm; Waters 991-PDA system
Waters). A sample of 20mg from venomwas eluted with solvent B (acetonitrile, 0–66%) at 25∘C.The elution profile wasmonitored at 280 nm.
The main fractions obtained are identified as Bp-1–Bp-18.
(PND) and extensor digitorum longus (EDL) muscles iso-
lated from mice and biventer cervicis muscle (BC) isolated
from chick were mounted according to Bu¨lbring [25] and
Ginsborg and Warriner [26], respectively.
The PND and EDL mammal preparations were sus-
pended under a constant resting tension of 5 g/cm and
0.5 g/cm, respectively, in a 5mL (for PND) and 3.5mL (for
EDL) organ bath containing aerated (95% O
2
-5% CO
2
)
Tyrode solution, whose composition in mM was NaCl 137,
KCl 2.7, CaCl
2
1.8, MgCl
2
0.49, NaH
2
PO
4
0.42, NaHCO
3
11.9,
and glucose 11.1, pH 7.4, 37∘C. A supramaximal pulse (0.1 Hz,
0.2ms) delivered by a Grass S48 electronic stimulator (Grass
Instrument Co., Quincy, MA, USA) was applied through
electrodes placed around themotor phrenic nerve (PND) and
tendon (EDL). For both preparations, the isometric muscle
tension was recorded using a force-displacement transducer
Load Cell BG 50 g (Kulite Semiconductor Products Inc.,
Leonia, NJ, USA) coupled to a physiograph (Gould RS 3400,
Cleveland, OH,USA).ThePNDpreparationswere allowed to
stabilize for at least 20min before the addition of Bp-13 toxin
at different concentrations: 0.71𝜇M (10 𝜇g/mL), 1.42 𝜇M
(20𝜇g/mL), 3.56 𝜇M (50 𝜇g/mL), and 7.12 𝜇M (100𝜇g/mL).
The EDL preparations were incubated with Bp-13 toxin at
3.56 𝜇M.
Some curarized PND preparations (d-tubocurarine,
10 𝜇M) were incubated with Bp-13 toxin at 1.42 𝜇M and
3.56 𝜇Mconcentrations and the twitch responsewas recorded
under direct muscle stimulation at supramaximal pulses of
70V, 0.1 Hz at 2ms duration.The effect of divalent ions,Mg2+,
Mn2+, Sr2+, and Cd2+ (10mM), on the Bp-13 PLA
2
activity
was done by replacement of Ca2+ (1.8mM) in the nutritive
Tyrode solution; replacement ofCa2+ by Sr2+ (4mM)was also
assayed. The effect of temperature (5 to 60∘C) during 20min
was read at 425 nm.
The biventer cervicis (BC) preparations were suspended
in a 5mL organ bath containing Krebs solution (composition
in mM: NaCl 118.6, KCl 4.69, CaCl
2
1.88, KH
2
PO
4
1.17,
MgSO
4
1.17, NaHCO
3
25.0, and glucose 11.65), aerated with
carbogen (95% O
2
-5% CO
2
) at 37∘C. A bipolar platinum ring
electrodewas placed around themuscle tendon,withinwhich
run the motor nerve trunk. Field stimulation using a Grass
S48 stimulator set at 0.1 Hz, 0.2ms, and 4–6V was applied
and the muscle contractions and contractures were recorded
isometrically via force-displacement transducer coupled to a
physiograph. The muscle responsiveness to exogenously
applied acetylcholine (ACh, 110 𝜇M) and KCl (13.4mM) was
recorded in the absence of field stimulation both prior to
toxin addition and at the end of the experiment (120min).
The BC preparation was stabilized for at least 15min before
addition of Bp-13 at concentration of 3.56 (50𝜇g/mL) and
7.12 𝜇M (100 𝜇g/mL).The results were compared with control
BC preparations incubated with Krebs solution alone.
2.8. Statistical Analyses. Results were reported as mean ±
SEM. Differences among means was assessed by one-way
ANOVA and followed byMann-Whitney test for comparison
between two groups. Differences were considered statistically
significant if 𝑃 < 0.05.
3. Results
3.1. Purification and Characterization. Fractionation of B.
pauloensis venom by reverse phase HPLC (Figure 1) showed
the elution of 18 main fractions: Bp-1 to Bp-18. The Bp-13,
which was eluted at 39min, was characterized as a not yet
described PLA
2
-active toxin (Figure 2(a)). The purity of this
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Figure 3: Mass determination of Bothrops pauloensis Bp-13 by
MALDI-TOF mass spectrometry.
peakwas confirmed through rechromatography on an analyt-
ical RP-HPLC 𝜇-Bondapak C18 column and showing a single
peak (Figure 1, insert).
Tricine SDS-PAGE and MALDI-TOF mass spectrometry
showed that Bp-13 PLA
2
presented a molecular mass of
∼14 kDa (Figure 2(b)) and 14035.628Da (Figure 3), respec-
tively.The amino acid analysis revealed the following compo-
sition: Asx/9, Glx/5, Ser/4, Gly/13, His/2, Arg/5, Thr/7, Ala/6,
Pro/11, Tyr/14, Val/4, Cys/14, Ile/3, Leu/11, Phe/3, and Lys/12
with a high content of basic and hydrophobic amino acids
and 14 half-cystine residues. Its N-terminal sequence of the
52 initial residues was as follows: DLWQFGKMIL KENGK-
SPFSF YGAYGCYGGW GGRRKPKDKT TDRCCFVHDC
CR. Such amino acid sequencing of Bp-13 PLA
2
shares 95%
sequence identity with other bothropic PLA
2
s (Figure 4).
3.2. Enzymatic Characterization of Bp-13 PLA
2
. The Bp-13
PLA
2
activity measured through synthetic substrate 4-nitro-
3-octanoyloxy-benzoic acid and 1–20mM Ca2+ showed that
the catalytic activity was expressed after 2mM Ca2+, but
the maximal PLA
2
activity was reached with 10mM Ca2+
(Figure 5(a)). For the conditions tested, Bp-13 PLA
2
showed
a discrete allosteric-like behavior, mainly at low sub-
strate concentrations (Figure 5(b)). Estimated 𝑉max was
11.6 nmol/min/mg and 𝐾
𝑚
was 11.8mM (Figure 5(c)). The
optimal pH and temperature for development of the max-
imum enzymatic activity were 8.3 (Figure 5(d)) and ∼38∘C
(Figure 5(e)), respectively. The addition of Mn2+, Mg2+, Sr2+,
and Cd2+ (10mM) in the presence of low Ca2+ concentration
(1mM) decreased enzyme’s activity; the substitution of Ca2+
byMn2+, Mg2+, Sr2+, or Cd2+ (10mM) in the absence of Ca2+
(0mM) also reduced PLA
2
activity (Figure 5(f)). In addition,
preincubation with urea (4M) did not affect significantly the
enzymatic activity of Bp-13 (data not shown).
3.3. Neuromuscular Activity. Assays to study the neuromus-
cular activity of Bp-13 PLA
2
were performed using avian BC
preparation and rodent’s PND and EDL preparations. The
toxin induced a time- and concentration-dependent and irre-
versible twitch-tension blockade. In the PND preparations,
the time needed for 50% paralysis in response to 7.12𝜇M (𝑛 =
3), 3.56 𝜇M(𝑛 = 6), and 1.42 𝜇M(𝑛 = 3) of Bp-13 PLA
2
was 18
± 1min, 28 ± 3min, and 120 ± 4min, respectively (𝑃 < 0.05);
Bp13 at 0.71 𝜇M concentration induced a 25% paralysis only
after 120 ± 2min relative to control (𝑃 < 0.05) (Figure 6(a)).
The catalytic activity of Bp-13 PLA
2
was similar both in the
presence of 1 or 10mM in the nutritive bath of PND prepara-
tion. The addition of Mg2+, Mn2+, Sr2+, and Cd2+ (10mM)
in the nutritive Tyrode solution in the absence of Ca2+ or
presence of 1mMCa2+ showed significant loss of the catalytic
activity of the toxin indicating that these divalent ions cannot
replace the Ca2+ for the development of the PLA
2
catalytic
activity. The replacement of 1.8mM Ca2+ by 4mM Sr2+ in
the Tyrode solution prevented the blocking effect of Bp13
PLA
2
(3.56 𝜇M) since the twitch-tension response showed
an amplitude of 83.7 ± 14% after 120min incubation which
was not different from baseline of the control preparations
(Figure 6(b)). The finding indicates that the neuromuscular
blocking effect of the Bp-13 is calcium-dependent.
The effect of temperature (5∘C–60∘C) on the catalytic
activity of Bp-13 PLA
2
showed that the optimal enzymatic
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Figure 4: The amino acid sequence N-terminal, alignment of Bp-13 with selected PLA
2
sequences obtained from the BLAST protein data
bank (PubMed–Medline). PrtTX III from Bothrops pirajai [55], PLA
2
Bj p from Bothrops jararacussu [30], PLA
2
6-1 and PLA
2
6-2 [22] and
BthTx-II, bothropstoxin II, from Bothrops jararacussu [56], BnpTX-I and BnpTX-II [32], and NeuTX-I [12].
activity occurred around 38∘C (Figure 6(c), insert). The neu-
romuscular blockade was prevented when the temperature
incubation was set at 24∘C; after 120min, the twitch-tension
response was 37.4% compared with the 90% seen at 37∘C,
Figure 6(c). The PND preparations previously treated with
d-Tc (10 𝜇M) and under direct electrical stimulation showed
that Bp-13 (1,42 and 3.56 𝜇M) was able to cause a significant
contracture followed by blockade of the contractile response
(73 ± 7% and 14 ± 6%, respectively, 𝑛 = 3–6, 𝑃 < 0.05,
Figure 6(d)).
In the EDL preparations, the time needed for 50%
paralysis at a 3.56𝜇MBp13PLA
2
concentrationwas 120min±
2min (Figure 7). As displayed in the Figure 7, the contractile
response of the EDL preparation was maintained steady
during the 60min period, regardless of whether the EDL was
incubated in normal Tyrode solution or in Tyrode solution
whose Ca2+ (1.8mM)was replaced by Sr2+ (4mM).TheBp-13
(3.56 𝜇M) addition caused a significant blockade of the twitch
tension which achieved 90% after 80min of toxin addition in
the normal Tyrode solution.The replacement of 1.8mMCa2+
by 4mMSr2+ also prevented completely such neuromuscular
blockade induced by the toxin (3.56𝜇M)whichwas sustained
until the end of observation (180min, 𝑛 = 6, 𝑃 < 0.05).
Similarly, the lowering of temperature to 24∘C prevented
the blockade of twitch tension in the EDL preparation (not
shown).
In relation to avian preparations, it was shown that they
exhibited lower sensibility to Bp-13 PLA
2
than the mam-
malian preparations. Bp-13 PLA
2
(3.56 and 7.12 𝜇M) induced
an irreversible but mild decrease of the twitch tension of 21 ±
6% and 28 ± 2% after 120min, respectively (Figure 8(a)). The
response to acetylcholine (ACh, 110 𝜇M) was significant just
whenBp-13 PLA
2
concentrationwas set at 7.12𝜇M(𝑃 > 0.05).
In contrast, Bp-13 PLA
2
regardless of the concentration, 3.56
or 7.12 𝜇M, did not interfere in the KCl (13.4mM) induced
contracture (Figure 8(b)).
4. Discussion
The presence of Bp-10 and Bp-11 (K49 PLA
2
homologous
Bnsp 6 and Bnsp7) [8], Bp-14 and Bp-15 (Asp49 PLA
2
NeuTX-I and NeuTX-II) [12], and Bp-12 (Lys49 PLA
2
) [11]
has been already demonstrated in the B. pauloensis snake
crude venom. Interestingly, another Asp49 PLA
2
, the Bp13,
of the same Bothrops species venom was now isolated and
characterized biochemically and pharmacologically. Such a
diversity of PLA
2
isoforms in the venom of a same species
evidences the necessity of developing efficient methodologies
to purify and identify different isoforms in venom frac-
tions otherwise considered homogeneous.TheRP-HPLCwas
more suitable to purify Bp-13 PLA
2
than other conventional
methods previously described for other toxins of the same
venom, since it required just a single chromatographic step
[19, 22, 27].
The purity of Bp-13 PLA
2
was confirmed by rechromatog-
raphy on an analytical RP-HPLC 𝜇-Bondapak C18 column.
SDS-PAGE showed the monomeric nature of Bp-13 and a
relative molecular mass of ∼14 kDa and it was confirmed by
MALDI-TOF mass spectrometry with a molecular mass of
14035.628Da.MALDI-TOF/MS has a precision inmeasuring
protein molecular mass of 0.1% Da; thus, this characteristic
allows us to demonstrate that Bp13 is another PLA
2
isoform
present in the Bothrops pauloensis venom, as was for other
bothropic PLA
2
isoforms [19, 22, 27–32].
The amino acid composition of Bp-13 PLA
2
suggests
that this PLA
2
is a basic protein because it possesses more
basic residues (Arg, His, and Lys, total 19) than acid residues
(Asx/Gnx, total 13), 14 half- Cys, and also because this protein
showed high content of residues Tyr, Pro, Gly, and Lys which
was a composition featured by other catalytic active bothropic
myotoxins such as the 6-1 PLA
2
and 6-2 PLA
2
isoforms from
B. jararacussu orthe BaTX, a basic PLA
2
from B. alternatus
[22, 27].
In Asp49 PLA
2
, a conserved N-terminal helix region
forms a hydrophobic channel involving L2, Q4, F5, and I9.
Conversely, the level of identity between PLA
2
s is very high
in Ca2+-loop sequence (residues 24–34 YGCXCGXGGRG)
and in the active site (residues 42–54 DRCCFVHDCCYXK)
[22, 33–35]. The conserved residues Y28, G30, G32, Asp49,
H48, and Y52 are directly or indirectly linked to Bp-13 PLA
2
catalysis. The N-terminal amino acid sequence of the first 52
residues from Bp-13 PLA
2
shows these regions highly con-
served and directly linked to catalytic activity.
Bp-13 PLA
2
herein analyzed showed the presence of some
important mutations in N-terminal sequence (up to the 52nd
residue). Thus, Bp-13 PLA
2
shows K7 -> Q7, N13 -> T13, F20
-> Y20, R34 -> G34, and F46 -> Y46, which are strategic
positions for expression of the catalytic activity.The presence
of K7 in Bp-13 PLA
2
shows that this residue can contribute
to keep hydrophobic cavity conformation of the N-terminal
region. The N-terminal channel present in PLA
2
enzymes is
highly conserved and provides access to the lipid substrate to
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Figure 5: Kinetic analysis of Bp-13 PLA
2
activity. (a) Influence of calcium ion on PLA
2
activity; (b) effect of substrate concentration on the
kinetics of Bp-13 PLA
2
; (c) Lineweaver-Burk (double-reciprocal) plot of Bp-13 PLA
2
; (d) optimal pH for PLA
2
activity; (e) optimal temperature
for PLA
2
activity; (f) influence of ions (10mM each) on PLA
2
activity in the absence or presence of 1mM and 10mMCa2+. The results are the
mean± SEMof five experiments. ∗𝑃 < 0.05when comparedwith control values. ANOVA and followed byMann-Whitney test for comparison
between two groups.
Biochemistry Research International 7
∗
Tyrode
0.71𝜇M
1.42𝜇M
3.56𝜇M
7.12 𝜇M
Tw
itc
h 
te
ns
io
n 
(%
)
100
80
60
40
20
0
120100806040200
Time (min)
∗∗∗
∗∗∗
∗
∗∗∗
∗∗
∗∗
∗
∗
∗
∗
∗∗∗∗
∗∗
∗∗
∗
∗
∗
∗∗
∗∗
∗
∗
∗
∗
(a)
11
10
9
8
7
6
5
4
3
2
1
0
V
o
(n
m
ol
/m
in
)
Ca
2
+
[1
m
M
]
Ca2+[1mM]
Ca
2
+
[1
0
m
M
]
Ca
2
+
[0
m
M
]
Ca2+[0mM]
M
g2
+
M
n2
+
Sr
2
+
C
d2
+
M
g2
+
M
n2
+
Sr
2
+
C
d2
+
120100806040200
Time (min)
Tw
itc
h 
te
ns
io
n 
(%
)
100
120
80
60
40
20
0
Control
3.56𝜇M
(b)
10
0
8
6
4
2
0
10 20 30 40 50 60
V
o
(n
m
ol
/m
in
)
Tw
itc
h 
te
ns
io
n 
(%
)
100
80
60
40
20
0
120100806040200
Time (min)
Control (24∘C)
3.56𝜇M (24∘C)
∗
∗ ∗
∗ ∗ ∗ ∗ ∗ ∗
Temperature (∘C)
(c)
Tyrode
1.42𝜇M
3.56𝜇M
120100806040200
Time (min)
Tw
itc
h 
te
ns
io
n 
(%
)
100
80
60
40
20
0
∗∗
∗∗∗∗
∗
∗∗
∗
∗
∗
(d)
Figure 6: Twitch-tension response of direct and indirect stimulated PND preparations for 120min. (a)The preparations were incubated with
Tyrode (control) or Bp-13 PLA
2
(0.71–7.12𝜇M) at 37∘C (𝑛 = 3–6 experiments); (b) twitch-tension response of PND preparations incubated
with Bp-13 PLA
2
in Tyrode solution and in Tyrode whose 1.8mM Ca2+ was replaced by 4mM Sr2+ at 37∘C (𝑛 = 4–6); (c) twitch-tension
response of indirectly stimulated PND preparations incubated with Tyrode (control) or Bp-13 (3.56 𝜇M) at 24∘C (𝑛 = 4–6 experiments);
(d) twitch-tension response of directly stimulated PND preparations incubated with Tyrode (control) or Bp-13 (1.42 and 3.56𝜇M) at 37∘C
(𝑛 = 4–6 experiments). Twin arrows represent the time of toxin addition. Each point represents the mean ± SEM; ∗𝑃 < 0.05 compared to
control values. ANOVA and followed by Mann-Whitney test for comparison between two groups.
the PLA
2
catalytic site. Also, Bp-13 shows at position 13 the
lack of Thr residue usually found in other PLA
2
s enzymes;
however, both BnpTX-I (A13 -> T13) and NeuTx-I (A13 ->
T13) also showed mutation in this position for polar residue,
suggesting that this position is not as well conserved and that
it could be a structural feature for the PLA
2
of B. pauloensis.
The same was observed for the position 16, but in this par-
ticular case this position conserved its hydrophobic nature.
Despite the change, Bp-13 still maintains catalytic activity
and indicates that these residues have no important role
in Bp-13 activity [33, 36].
Breithaupt [37] reported thatCrotalus PLA
2
shows classic
Michaelis-Menten behavior. However, PLA
2
activity of Bp-13
from B. pauloensis shows a discrete allosteric-like behavior,
and this activity is enhanced by the presence of even lowCa2+
concentrations. The PLA
2
from C. durissus terrificus venom
exhibits a typical PLA
2
activity, since it hydrolyzes synthetic
substrates at position 2 and preferentially attacks substrates
in their micellar state [24, 37]. Similarly, Bp-13 PLA
2
exhibits
allosteric behavior with a 𝑉max of 11.6 nmol/min and a 𝐾𝑚 of
11.8mM.
However, at low concentrations of the synthetic substrate,
Bp-13 PLA
2
showed a sigmoidal kinetic behavior; this phe-
nomenonwas observed for otherCrotalinae PLA
2
s [2, 22, 38–
40], suggesting an allosteric behavior for these enzymes. The
allosteric term was originally used for enzymes with altered
kinetic properties in the presence of ligands (effectors) that do
not show any structural similarity to the substrate. Allosteric
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enzymes show a number of properties that distinguish them
from the nonallosteric ones. Sigmoidal kinetics in the velocity
substrate curve, the existence of effectors, and a polymeric
structure are some of the properties of a genuine allosteric
enzyme. In the case of Crotalinae D49-PLA
2
, SDS-PAGE
without reducing agents showed a weak band at ∼28 kDa
[2, 40] indicating that some molecule populations of these
enzymes exist in a dimeric form, which could be responsible
for the observed enzymatic behavior.
Bp-13 PLA
2
was resistant to heat and acid like PLA
2
s from
Crotalus d. cascavella [38, 41], C. d. collilineatus, and Lachesis
muta muta [42] venoms; Bp-13 optimal activity was at pH
8.3 and was inactivated at pH higher than 9, like the PLA
2
from C. mitchelli pyrrhus [24], C. d. terrificus [43], and B.
neuwiedi [44] snake venoms.Themaximal enzymatic activity
occurred at ∼38∘C and persisted at 60∘C, indicating a heat-
stable enzyme.
Pharmacologically, as for other types of PLA
2
, the activity
of Bp-13 PLA
2
was shown to be completely Ca2+-dependent
[45].The coincubation of Bp-13 PLA
2
with other divalent ions
(Mg2+,Mn2+, Sr2+, andCd2+) in the presence of 1mMCa2+ or
in Ca2+ absence reduced or abolished the enzymatic activity.
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The Ca2+ replacement by 4mM Sr2+ abolished the neu-
romuscular blockade. It is well known that calcium ions are
essential cofactors for the enzymatic activity of both toxic
and nontoxic phospholipases A
2
[46]. Several divalent ions,
including Sr2+, can bind to the same site of the Ca2+, allowing
neuromuscular transmission; nevertheless, this ion does
not substitute Ca2+ in the catalysis processes [47–50]. Thus,
the observation that neuromuscular effect of Bp-13 was Ca2+-
dependent indicates that the enzymatic activity might con-
tribute for such effect as for neuwieditoxin I and neuwied-
itoxin II, an Asp49 PLA
2
from B. pauloensis [12]. Also, the
lowering of the temperature of incubation bath to 24∘C
abolishing the neuromuscular effect of Bp-13 indicates that
the enzymatic activity has a role on the neuromuscular action
in PND and EDL preparations. Such finding is similar to
the one observed by Galbiatti et al. [14] with Bmaj-9 PLA
2
from B. marajoensis venom, also an Asp49 PLA
2
. Likewise, a
high catalytic activity was found in neuwieditoxin-I and -II
Asp49 PLA
2
s, whose neuromuscular blockade was also
temperature-dependent [12]. Both the dependence of Ca2+
and the need of temperature equal or above 30∘C for enzy-
matic activity of Bp-13 identify the toxin as a typical Asp49
PLA
2
.
Bothropic envenomation does not cause neurotoxic clini-
cal signs, but some experimental studies have shown that the
venom of several species causes neuromuscular blockade in
vitro [8, 11–14, 32, 51, 52] and induces peripheral muscular
weakness signs [6, 53].
Borja-Oliveira et al. [54] reported thatB. pauloensis crude
venom causes partial blockade of directly evoked muscular
contractions in BC preparations; in 2007, the authors sug-
gested that neuwieditoxin-I and -II (Asp49 PLA
2
s) from B.
pauloensis venom were probably responsible for the venom
presynaptic neurotoxicity in vitro. However, herein it was
shown that BC preparations showed low responsiveness to
the Bp-13 (less than 30% of neuromuscular blockade) when
compared to the crude venom.This couldmean that this new
Asp49 PLA
2
from B. neuwiedi venom has preponderantly a
muscular action, thus differing from the presynaptic neuro-
toxic action of neuwieditoxin-I and -II Asp49 PLA
2
s referred
by Borja-Oliveira et al. [12].
Taken together, these results identify Bp-13 isolated from
Bothrops pauloensis snake venom, as a new member of the
Asp49 PLA
2
family. It is suggested that the Bp-13 PLA
2
catalytic activity may contribute to the neuromuscular effect
already reported for the crude venomon rodent preparations.
It is suggested that the main effect of the Bp-13 toxin seems
to be on the fiber sarcolemma, with prominence in the mice
preparation. In BCpreparations, the Bp-13 PLA
2
showed little
neuromuscular effect.This study is an additional contribution
for understanding the toxic effect caused by the Bothrops
pauloensis crude venom.
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